Fundraising Fox

Biotech Investors & VC Firms in United States

564 firms in this list, with a median first check of $500K. 46 of them lead rounds. Generated from verified public data and updated continuously.

b2venture
BerlinPre-Seed–Late Stage$270K – $5.4M
11 people
BPOC
ChicagoGrowth$25M – $100M
11 people
EQT Life Sciences
AmsterdamSeries A–Late Stage$10.8M – $64.8M
11 people
Frazier Healthcare Partners
SeattleGrowth$50M – $400M
11 people
Gilde Healthcare
UtrechtSeed–Late Stage$1.1M – $32.4M
11 people
Hercules Capital, Inc.
San MateoSeed–Late Stage$500K – $50M
11 people
Horizon Technology Finance
FarmingtonGrowth$3M – $50M
11 people
JJDC
New BrunswickSeed–Series B$500K – $5M
11 people
K2 HealthVentures
BostonSeries A–Series B$10M – $100M
11 people
MVM Life Science Partners
BostonSeed–Late Stage$3.8M
11 people
NaviMed Capital
RosslynGrowth$5M – $30M
11 people
Oxford Finance LLC
AlexandriaSeed–Late Stage$500K – $40M
11 people
PAI Partners
Paris$108M – $324M
11 people
Sante Ventures
AustinSeed–Series A$2M – $6M
11 people
Yuanta Investment
SeoulSeed–Late Stage$1M – $15M
11 people
Refactor Capital
Silicon ValleySeed–Series A$1M – $2M
2 people
Domain Associates
PrincetonSeed–Series C$200K – $15M
4 people
Avego BioScience Capital
AlpharettaSeries B–Late Stage
Frazier Life Sciences
Palo AltoSeed–Series B
11 people
Borealis Ventures
HanoverPre-Seed–Seed$1M – $2.5M
4 people
China Growth Capital
BeijingPre-Seed–Series A
3 people
Slater Technology Fund
ProvidencePre-Seed–Series A
2 people
PBM Capital
CharlottesvilleSeed–Late Stage
6 people
Ballast Point Ventures
TampaGrowth–Late Stage$5M – $15M
10 people

Related lists

Data sourced from public filings and firms' own websites — see our methodology.